Dariolo, R. “Impact of Enhanced Compliance Initiatives on the Efficacy of Rosuvastatin in Reducing Low Density Lipoprotein Cholesterol Levels in Patients With Primary Hypercholesterolaemia”. Swiss Medical Weekly 138, no. 2930 (July 26, 2008): 420–426. Accessed May 3, 2024. https://smw.ch/index.php/smw/article/view/876.